Multiple-target Therapy for Posttransplant Focal Segmental Glomerulosclerosis.

Juliana Mansur, Domingo Chang-Dávila, Marcela Giraldes Simões,Marina Pontello Cristelli,Suelen Bianca Stopa Martins, Henrique Machado de Sousa Proença,Laila Almeida Viana, Alexandra Nicolau Ferreira, Marisa Petrucelli Doher,José Medina-Pestana,Gianna Mastroianni Kirsztajn,Helio Tedesco-Silva

Transplantation direct(2024)

引用 0|浏览2
暂无评分
摘要
Background:There is no consensus on the ideal strategy to treat posttransplant focal segmental glomerulosclerosis. The multiple-target therapy, which consisted of high-dose intravenous cyclosporine, prednisone, and plasmapheresis, showed favorable results. Methods:This single-center, prospective study sought to evaluate the multiple-target therapy in an independent cohort of patients. Results:Thirteen patients with posttransplant focal segmental glomerulosclerosis received multiple-target therapy. Complete remission was achieved in 2 patients (15.4%), and partial remission in another 2 patients (15.4%). Four patients (30.7%) did not show remission, and 5 patients (38%) lost the graft because of posttransplant focal segmental glomerulosclerosis during the 12-mo follow-up. Premature discontinuation of treatment occurred in 10 patients (77%), all associated with infectious adverse events. Cytomegalovirus was the most common complication, and preemptive therapy was used instead of prophylaxis. Conclusions:In this cohort of patients, the efficacy of the multiple-target therapy was poor and limited by the high incidence of infectious adverse events.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要